Summary:
Trial evaluating the efficacy of antithrombotic strategies in COVID-19 adults not requiring hospitalization at time of diagnosis.
Qualified Participants Must:
• Test positive for COVID-19 within the past 14 days
•
Above 40 y/o
Qualified Participants May Receive:
Qualified participants will recieve $ 100 at enrollment and $ 95 at completion of the trial.